News
We send the latest information from SMC Laboratories.
GN Corporation publication in Journal of Clinical and Experimental Hepatology
SMC announces that GN Corporation Clinical and Experimental Hepatology (Japan) has published the results of a …
Esperion Therapeutics's publication in Cell Metabolism
SMC announces that Esperion Therapeutics (MI, USA) has published the results of a study using STAM™ …
Potential NASH biomarker in NASH-HCC model
We would like to introduce the data for a serological marker from our NASH model (STAM™ model). Hepatoce…
Drug efficacy studies in NASH mouse model
We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis…
Introducing our new model: DDC-induced liver injury model
We introduce the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced liver injury model*, a well-known mod…
Reserve a non-clinical pharmacology consultation with us at BIO KOREA 2022!
We will join BIO KOREA 2022 International Convention, one of the biggest bio-health conventions in Asia. BIO K…
kk
We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis…
Introduction of the paper using our UUO model
We would like to introduce a paper published by our client using Chronic kidney disease model. &…
Change in concept from non-alcoholic fatty liver disease to metabolic disorder related fatty liver disease
You may be aware of NAFLD (non-alcoholic fatty liver disease), but have you heard of MAFLD? Metabolic dysfunct…
Drug efficacy studies using multiple mouse models to replicate human disease.
To date, numerous clinical trials have been conducted using existing and newly developed drugs in the field of…